• Bio Essence shareholders authorized an articles amendment granting each preferred share 10,000 votes, compared with one vote per common share.
• Shareholders holding 34,396,000 common shares, representing 63.93% of outstanding common stock on October 19, 2026, backed the amendment.
• No preferred shares are currently outstanding; future holders would receive supervoting rights.
• The amendment would enable future preferred stock issuance to maintain or transfer control without diluting common stock holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Essence Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111239), on October 21, 2026, and is solely responsible for the information contained therein.